Stacy Simons, NP
Family · la Jolla, CANPI 1952844185
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 24.6% of the total. 2025 is the largest year on record at $2,279, more than ten times the $197 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$486
- Teva Pharmaceuticals USA, Inc.$322
- UCB, Inc.$308
- Neurocrine Biosciences, Inc.$235
- Pfizer$192
- plus $2K from 31 others
What the payments were for
- Travel & lodging$90%
- Food & beverage$4,14097%
- Education$1022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $1,047 |
| Lilly USA, LLC | 19 | $486 |
| Teva Pharmaceuticals USA, Inc. | 19 | $322 |
| UCB, Inc. | 12 | $308 |
| Neurocrine Biosciences, Inc. | 11 | $235 |
| Pfizer | 9 | $192 |
| SK Life Science, Inc. | 6 | $174 |
| Neurelis, Inc. | 6 | $116 |
| Incyte Corporation | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Medtronic | 1 | $102 |
| Corium, LLC | 4 | $88 |
| Argenx US, Inc. | 3 | $78 |
| Genentech USA, Inc. | 3 | $68 |
| Amneal Pharmaceuticals LLC | 3 | $65 |
| Catalyst Pharmaceuticals, Inc. | 3 | $61 |
| Grifols USA, LLC | 3 | $60 |
| Eisai Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Biogen | 2 | $52 |
| Lundbeck LLC | 2 | $50 |
| GSK | 2 | $43 |
| Tersera Therapeutics LLC | 1 | $37 |
| MDD US Operations, LLC | 1 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Tonix Medicines, Inc. | 2 | $32 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| AstraZeneca | 1 | $26 |
| Merck | 1 | $24 |
| CSL Behring | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Impel Pharmaceuticals LLC | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$243
- OPZELURA$116
- PERCEPT PC BRAINSENSE$102
How this compares
$4,252 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 587 | $26,623 |
| Donepezil Hcl | 488 | $5,986 |
| Lacosamide | 44 | $5,136 |
| Gabapentin | 151 | $2,660 |
| Levetiracetam | 80 | $2,623 |
| Lamotrigine | 99 | $1,970 |
| Memantine Hcl ErMemantine Hcl | 20 | $1,497 |
| Quetiapine Fumarate | 41 | $1,158 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 35 | $990 |
| Topiramate | 53 | $705 |
| Carbamazepine | 22 | $696 |
| Divalproex Sodium | 19 | $654 |
| RivastigmineRivastigmine Tartrate | 12 | $651 |
| Mirtazapine | 22 | $570 |
| Pregabalin | 20 | $483 |
Paid to pharmacies, not to this prescriber.
Other family in la Jolla
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.